Immunohistochemical analysis revealed marked upregulation of both LAPTM4B (Fig. 6J, Fig. 1G) and ATP1A1 (Fig. 6J-K) in post-resistance tumor samples compared to matched pre-treatment samples from the same patients. Here, ATP1A1 is linked to neoplasm.